Norio Tada
Latest contributions
Mastering TAV-in-SAV: strategies, challenges and advanced techniques
09 Feb 2025 – From PCR Tokyo Valves 2025
Want to master the ins and outs of TAV-in-SAV? Don’t miss these presentations!
You’ll get expert guidance on evaluating feasibility, choosing the right transcatheter valve and using advanced techniques (valve fracture, leaflet modification, coronary protection...). Plus, you'll dive into multiple real-world case presentations that tackle challenges, share...
Coronary access after TAVI: timing and techniques
09 Feb 2025 – From PCR Tokyo Valves 2025
Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:
- Case 1: Managing a patient with...
TAV-in-SAV - Part 1
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the complex world of TAV-in-SAV (Transcatheter Aortic Valve-in-Surgical Aortic Valve) in this comprehensive session. Explore various case studies, including valve-in-valve TAVI in a patient with structural valve deterioration, a successful case of balloon-assisted BASILICA for TAV-in-TAV, and TAVI after valve sparing aortic replacement. Gain...
Management of paravalvular leak
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this comprehensive session on the management of paravalvular leaks, a challenging complication following surgical or transcatheter valve replacements. Discover insights into managing post-operative pulmonary edema, percutaneous closure of left ventricular septal defects, and the nuances of mitigating recurrent paravalvular leaks. Dive into complex cases involving...
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
How to optimise lifetime management of TAVI patients with long life expectancy?
17 Feb 2024 – From PCR Tokyo Valves 2024
In this special session sponsored by Abbott, gain insight into how valve design and features may influence clinical outcomes and future interventions. Learn about hemodynamic efficiency of TAVI valves, and understand the factors influencing durability and clinical performance over time.
Facilitating coronary access after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
What are the challenges in coronary access after TAVI and what techniques may be used to facilitate it? Join this session to learn the answers to that question, as well as gaining insight into how to optimize the coronary access in the index procedure.
PCI after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, examine selected cases of percutaneous coronary intervention after TAVI. Explore the case of a successful bailout PCI with en-face view for sinus sequestration after self-expandable TAVI, learn about best management of previous implanted chimney stent during TAVI, and more.
TAV-in-TAV and coronary access
17 Feb 2024 – From PCR Tokyo Valves 2024
Learn about the challenges of coronary access during TAV-in-TAV procedure through this series of abstract submissions for PCR Tokyo Valves 2024. Expore the feasibility of redo TAVR in Sapien valves based on in-vivo CT assessment, examine the coaxiality of transcatheter aortic self-expanding valve, and more in...
TAVI in small annulus and coronary artery disease - Session with LIVE case
19 Feb 2023 – From PCR Tokyo Valves 2023
Watch the complex case of an 84-year-old woman with hypertension, type 2 diabetes and coronary artery disease who presented with worsening NYHA class II-III exertional dyspnoea, but no angina, and find out how she was treated LIVE.
Technical challenges and optimal device choice for complex TAVI procedures
18 Feb 2023 – From PCR Tokyo Valves 2023
This session reflects on the importance of device choice and implantation technique in complex TAVI procedures. Uncover challenges in TAVI for failed bioprostheses and bicuspid aortic valves, emphasising optimal device selection and exploring the latest evolutions in TAVI such as the Medtronic.
TAVI in a patient with heavily calcified valve anatomy - LIVE case
18 Feb 2023 – From PCR Tokyo Valves 2023
An 80-year-old male with chronic kidney disease and interstitial pneumonia treated under steroids presented a symptomatic severe aortic stenosis with massive calcifications on the valves and only on the valves (not the LVOT).
Watch the operators implant a Sapien 3 23 mm (-1cc) with a predilatation (Balloon...
PFO closure
17 Feb 2023 – From PCR Tokyo Valves 2023
Consult this session to learn procedural tips and tricks and explore the role of PFO treatment for stroke prevention. Discover the evidence for PFO closure, when it should be considered, pre, intra and post procederal management, and common procedural complications.
Outlook on TAVI in Asian patients: how can the Navitor valve with the FlexNav delivery system enable successful procedural outcomes?
Watch this roundtable discussion between Dr Ravinder Singh Rao and Dr Norio Tada, moderated by Dr Michael Lee, to find out more about the prospects of TAVI in Asian patients.
This session will enable you to understand the special anatomical features of the Asian aortic valve stenosis...
TAVI procedure optimisation with the cusp overlap technique
27 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...
Bicuspid aortic valves: where do we stand?
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to learn more about bicuspid aortic valves: understand patient selection for TAVI, explore sizing and valve selection, and discover the key procedural steps for TAVI in bicuspid AV.
Sizes, wires, and other innovations in TAVI technique and technology
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on innovations in TAVI technique and technology to learn more about new self-expanding TAVR valve sizes and TAVR wires, emerging developments in self-expandable TAVR implant best practices, and discover how to utilize these new technologies and techniques to achieve the best possible outcomes for AS patients.
Remaining limitation of TAVI
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about the remaining limitation of TAVI, such as conduction abnormalities, coronary access, severe aortic valve calcification, thanks to a selection of various interesting cases.
Stroke Prevention Day - PFO
14 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn how to build a stroke prevention team, what are the indications and pre-procedural screening of PFO closure, and discover the step-by-step procedure of PFO closure thanks to a selection of cases and studies.
Excellent abstracts from Japan
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session in English and Japanese to learn more about various TAVI studies and cases, regarding topics such as comparison between self- and balloon- expandable valve, clinical outcomes of the 20mm SAPIEN 3, single proglide vascular preclose technique, and more!
Complications of TAVI
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about how to identify which patients are high risks for complication, how to use imaging in procedural planning, and how to treat TAVI related complications (valve embolization, paravalvular leak, and more!).
Challenging situations
17 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about how to prevent and treat periprocedural vascular complications, how to manage ECG conduction disturbances, and how to diagnose and treat valve thrombosis.
Hot topics in the pharmacologic treatment after TAVI – Current concepts
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session to learn more about the risk of valve thrombosis, thrombo-embolic and bleeding events after TAVI and the rationale of antithrombotic treatment regimens in atrial fibrillation patients post TAVI.
TAVI in a type 0 bicuspid aortic valve with low lying LM
16 Feb 2019 – From PCR Tokyo Valves 2019
Consult this session with LIVE demonstration from ICPS - Massy, France on a 61-year-old female with bicuspid aortic valve stenosis.
Clinical presentation:
- Femoral puncture with angio guidance
- Stimulation by LV wire
- Sapien 3 valve implanted
